Monepantel Phase 2 Study Results

PharmAust has announced positive top-line data from its Phase 2 veterinary clinical study of monepantel (MPL) for the treatment of Canine B-Cell Lymphoma. The company plans to use this data to open an Investigational New Animal Drug (INAD) application with the United States Food and Drug Administration’s (FDA) Center for Veterinary Medicine (CVM) and proceed with studies in 2024 to support product registration.

Pet Cancer Information Service

Promising Clinical Study for Dogs with Lymphoma – for this and any other information regarding advice for pets with cancer, please contact Dr. Catherine Chan:

Veterinary Study Testimonials

Chica from Brisbane

Chica was a Black Kelpie born on a farming property in WA. She was a very active and very smart little dog with and incredible capacity to respond to your mood.

Ruby from Brisbane

Ruby is our 12-year-old, black and tan Cavalier King Charles Spaniel. She is just the sweetest, gentle girl.

Ryley from Sydney

Ryley is our 5-year-old Border Collie x Kelpie. She is friendly, energetic, loyal, obedient, intelligent and inquisitive. She got her name from the country town where she was born – Rylestone.

Bella from Melbourne

Bella is aged six-and-a-half years and I have had her since she was a pup. She is family! Bella has a happy and friendly personality; her tail never stops wagging! She loves her food as well as getting her tummy scratched!

Louie from New Zealand

Louie is a 12-year-old Beagle and has been a beloved family pet for over 10 years. He’s a very happy dog, loves people, other dogs and life in general.

Learn More